Cadrenal Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible...

Related Keywords

New York ,United States ,Matthew Szot ,Robert Blum ,Douglas Losordo ,Quang Pham ,Lytham Partners ,Lotte New York Palace Hotel ,Cadrenal Therapeutics Inc ,Prnewswire Cadrenal Therapeutics Inc ,Nasdaq ,Annual Global Investment Conference ,Fast Track ,Cadrenal Therapeutics ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Trade Show News ,